Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Parasites & Vectors|October 14, 2015
Cutaneous leishmaniasis in the central provinces of Hama and Edlib in Syria: Vector identification and parasite typingNabil Haddad, Hanadi Saliba, Atef Altawil, et al.
Expert Review of Vaccines|September 23, 2017
Enhancing tumor specific immune responses by transcutaneous vaccinationHanadi Saliba, Béatrice Heurtault, Hasnaa Bouharoun-Tayoun, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 2, 2020
Liposomes as tunable platform to decipher the antitumor immune response triggered by TLR and NLR agonistsCélia Jacoberger-Foissac, Hanadi Saliba, May Wantz, et al.
International Journal of Pharmaceutics|March 19, 2019
Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platformCélia Jacoberger-Foissac, Hanadi Saliba, Cendrine Seguin, et al.
Progress in Retinal and Eye Research|February 1, 2026
Ocular gene therapy mediated by AAV vectors: an overview of immunosuppressive treatments and immunomonitoring of patients involved in clinical trialsDuohao Ren, Gaelle A Chauveau, Emilie Cabon, et al.
JCI Insight|June 9, 2026
CD8 T-cell activation occurs 24 hours post-AAV administration and is driven by muscle promoter specificityLindsay Jeanpierre, Coralie Pecquet, Hanadi Saliba, et al.
JCI Insight|February 18, 2026
Inter-individual variability in immune response to AAV ocular gene delivery across species impedes immunomonitoringDuohao Ren, Gaelle A Chauveau, Julie Vendomele, et al.
JCI Insight|May 16, 2024
Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liverLouisa Jauze, Mallaury Vie, Quentin Miagoux, et al.
Pageof 1